细胞外基质硬度通过Pin1调控转座子促进乳腺癌免疫逃逸
在细胞外基质硬度高的乳腺癌中,Pin1通过维持异染色质组织与核膜完整性抑制转座子活性,从而逃避免疫监视。Pin1缺失或药物抑制可激活cGAS/STING/Ⅰ型干扰素通路、促进转座子来源新抗原生成并重塑肿瘤免疫微环境,使纤维化免疫冷肿瘤对免疫检查点阻断敏感。
要点
- ECM硬度稳定Pin1并促进其核积累,维持HP1α-Lamin互作抑制转座子。
- Pin1缺失诱导异染色质松弛和LINE1再激活,激活cGAS/STING/Ⅰ型干扰素通路。
- 遗传或药物抑制Pin1可增敏纤维化免疫冷肿瘤对免疫检查点阻断的应答。
核心结论
- Pin1是ECM硬度驱动的免疫逃逸关键调控因子,靶向Pin1可恢复肿瘤免疫原性并改善免疫治疗疗效。
研究设计与样本
- 本文为原始研究(Cancer Discov),基于乳腺癌模型探讨ECM硬度通过Pin1调控转座子与免疫逃逸的机制。
主要发现
- ECM硬度稳定Pin1并促进其核积累,通过维持HP1α-Lamin互作保持异染色质组织和核膜完整性,抑制转座子活性。
- Pin1缺失引起早期异染色质松弛和LINE1再激活,激活cGAS/STING/Ⅰ型干扰素通路。
- Pin1缺失促进转座子来源新抗原生成并广泛重塑肿瘤免疫微环境,激发固有和适应性免疫应答增强肿瘤清除。
- 遗传缺失Pin1或使用临床可用药物进行药理学抑制,可使纤维化、免疫冷肿瘤对免疫检查点阻断敏感。
临床怎么用
- 对ECM硬度高、免疫冷乳腺癌,可考虑靶向Pin1(遗传缺失或临床可用药物抑制)以增敏免疫检查点阻断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breast cancers with a stiff extracellular matrix (ECM) frequently evade immune surveillance through mechanisms that remain incompletely understood. Here, we identify a mechanosensitive immune-evasion pathway governed by the phosphorylation-dependent prolyl isomerase Pin1. We show that ECM rigidity stabilizes Pin1 and promotes its nuclear accumulation in cancer cells, where it preserves heterochromatin organization and nuclear envelope integrity by sustaining HP1α-Lamin interactions, thereby suppressing transposable element (TE) activity. Pin1 loss induces early heterochromatin relaxation and LINE1 reactivation, activating the cGAS/STING/type I interferon pathway. Pin1 depletion further promotes TE-derived neoantigen generation and broadly remodels the tumor immune microenvironment, eliciting innate and adaptive immune responses that enhance tumor clearance. Genetic Pin1 depletion, or pharmacological inhibition with clinically available drugs, sensitizes fibrotic, immune-cold tumors to immune checkpoint blockade. These findings uncover a mechano-genomic mechanism of immune evasion in breast cancer and establish Pin1 as a therapeutic target to restore tumor immunogenicity and improve immunotherapy efficacy.
引用
- Bertolio, Rustighi, Renzi, et al. Extracellular matrix stiffness controls Transposable Elements through Pin1 to promote immune evasion in breast cancer. Cancer Discov. 2026. PMID: 42949540. doi:10.1158/2159-8290.CD-25-0942
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。